Table 2.
R-CEOP | R-CHOP | |
---|---|---|
Anthracycline received | ||
No anthracycline | 47 (67) | — |
Partial anthracycline | 23 (33) | — |
Reason for etoposide substitution | ||
Cardiac contraindication | 63 (90) | — |
Prior exposure | 5 (7) | — |
Other comorbidities | 2 (3) | — |
Treatment tolerance | ||
Percentage of deaths due to toxicity | 3 (4) | 5 (4) |
Completed planned treatment | 54 (78) | 110 (79) |
Data are presented as n (%) of patients.